Tech Company Financing Transactions

HemaQuest Pharmaceuticals Funding Round

On 4/22/2010, HemaQuest Pharmaceuticals received $12 million in Series B funding from Aberdare Ventures, De Novo Ventures and Forward Ventures.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

11995 El Camino Real 302
San Diego, CA 92130
USA

Phone

(858) 356-5590

Website

www.hemaquest.com

Email Address

[email protected]

Overview

HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Longenecker

        

Chief Financial Officer

Tamara Seymour

        

Chief Medical Officer

Richard Ghalie

        

Browse more venture capital transactions:

Prev: 4/22/2010: Code Green Networks venture capital transaction
Next: 4/22/2010: MXP4 venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary